Regulation of Expression and Pathogenic Potential of Human Foamy Virus In Vitro and in Transgenic Mice

Author(s):  
A. Aguzzi ◽  
S. Marino ◽  
R. Tschopp ◽  
A. Rethwilm
1998 ◽  
Vol 72 (7) ◽  
pp. 5510-5516 ◽  
Author(s):  
Otto Erlwein ◽  
Paul D. Bieniasz ◽  
Myra O. McClure

ABSTRACT A series of vectors with heterologous genes was constructed from HSRV1, an infectious clone of human foamy virus (HFV), and transfected into baby hamster kidney cells to generate stably transfected vector cell lines. Two cis-acting sequences were required to achieve efficient rescue by helper virus. The first element was located at the 5′ end upstream of position 1274 of the proviral DNA. Interestingly, a mutation in the leader sequence which decreased the ability to dimerize in vitro inhibited transfer by helper HFV. A second element that was important for vector transfer was located in thepol gene between positions 5638 and 6317. Constructs lacking this element were only poorly transferred by helper HFV, even though their RNA was produced in the vector cell lines. This finding rules out the possibility that the observed lack of transfer was due to RNA instability. A minimal vector containing only these two elements could be successfully delivered by helper HFV, confirming that all essential cis-acting sequences were present. The presence of a sequence described as a second polypurine tract in HFV was not necessary for transfer. Our data identified the minimal sequence requirements for HFV vector transfer for the development of useful vector systems.


Science ◽  
1991 ◽  
Vol 253 (5019) ◽  
pp. 555-557 ◽  
Author(s):  
K Bothe ◽  
A Aguzzi ◽  
H Lassmann ◽  
A Rethwilm ◽  
I Horak

2003 ◽  
Vol 31 (1_suppl) ◽  
pp. 103-110 ◽  
Author(s):  
Nicholas W. Lerche ◽  
Kent G. Osborn

Various species of nonhuman primates are natural hosts for 6 exogenous retroviruses, including gibbon-ape leukemia virus (GaLV), simian sarcoma virus, simian T-lymphotropic virus (STLV), simian immunodeficiency virus (SIV), simian type D retrovirus (SRV), and simian foamy virus (SFV). These viruses establish persistent infections with a broad spectrum of pathogenic potential, ranging from highly pathogenic to nonpathogenic, depending on various host, virus, and environmental factors. Latent or subclinical infections are common, and various procedures associated with experimental protocols may lead to virus reactivation and disease. Adverse effects on toxicologic research by undetected retroviral infections can occur in several ways, including loss of experimental subjects (and statistical power) due to increased morbidity and mortality. In addition, results may be confounded by virus-induced clinical abnormalities, histologic lesions, alteration of physiologic parameters and responses, and interference with in vitro assays and/or destruction of primary cell cultures. Key clinical and epidemiological features of several important retroviruses are reviewed, with emphasis on viruses infecting species of macaques most commonly used as research subjects in primate toxicology studies. Examples of actual and potential confounding of toxicologic studies by retroviruses are discussed, including altered cytokine profiles in healthy STLV carriers, and clinical and pathological abnormalities induced by SRV infection. Adequate prestudy viral screening is critical to exclude retrovirus-infected primates from toxicologic research protocols and prevent potential confounding of research results.


Intervirology ◽  
2002 ◽  
Vol 45 (2) ◽  
pp. 79-84 ◽  
Author(s):  
Zhi Li ◽  
Ping Yang ◽  
Hui Liu ◽  
Wen-xin Li

1996 ◽  
Vol 147 (1) ◽  
pp. 29-37 ◽  
Author(s):  
A. Sabile ◽  
A. Rhodes-Feuillette ◽  
F.Z. Jaoui ◽  
J. Tobaly-Tapiero ◽  
M.L. Giron ◽  
...  

1996 ◽  
Vol 70 (5) ◽  
pp. 2774-2780 ◽  
Author(s):  
J A Mikovits ◽  
P M Hoffman ◽  
A Rethwilm ◽  
F W Ruscetti

2001 ◽  
Vol 75 (8) ◽  
pp. 3731-3739 ◽  
Author(s):  
Dionne Cain ◽  
Otto Erlwein ◽  
Andrew Grigg ◽  
Rebecca A. Russell ◽  
Myra O. McClure

ABSTRACT The retroviral RNA genome is dimeric, consisting of two identical strands of RNA linked near their 5′ ends by a dimer linkage structure. Previously it was shown that human foamy virus (HFV) RNA transcribed in vitro contained three sites, designated SI, SII, and SIII, which contributed to the dimerization process (O. Erlwein, D. Cain, N. Fischer, A. Rethwilm, and M. O. McClure, Virology 229:251–258, 1997). To characterize these sites further, a series of mutants were designed and tested for their ability to dimerize in vitro. The primer binding site and a G tetrad in SI were dispensable for dimerization. However, a mutant that changed the 3′ end of SI migrated slower on nondenaturing gels than wild-type RNA dimers. The sequence composition of the SII palindrome, consisting of 10 nucleotides, proved to be critical for in vitro dimerization, since mutations within this sequence or replacement of the sequence with a different palindrome of equal length impaired in vitro dimerization. The length of the palindrome also seems to play an important role. A moderate extension to 12 nucleotides was tolerated, whereas an extension to 16 nucleotides or more impaired dimerization. When nucleotides flanking the palindrome were mutated in a random fashion, dimerization was unaffected. Changing the SIII sequence also led to decreased dimer formation, confirming its contribution to the dimerization process. Interesting mutants were cloned into the infectious molecular clone of HFV, HSRV-2, and were transfected into BHK-21 cells. Mutations in SII that reduced dimerization in vitro also abolished virus replication. In contrast, constructs containing mutations in SI and SIII replicated to some extent in cell culture after an initial drop in viral replication. Analysis of the SIM1 mutant revealed reversion to the wild type but with the insertion of an additional two nucleotides. Analysis of cell-free virions demonstrated that both replication-competent and replication-defective mutants packaged nucleic acid. Thus, efficient dimerization is a critical step for HFV to generate infectious virus, but HFV RNA dimerization is not a prerequisite for packaging.


Sign in / Sign up

Export Citation Format

Share Document